Abbott Laboratories (NYSE:ABT) Stock Rating Upgraded by Leerink Partnrs
Abbott Laboratories (NYSE:ABT – Get Free Report) was upgraded by investment analysts at Leerink Partnrs to a “hold” rating in a note issued to investors on Monday,Zacks.com reports. Leerink Partnrs also issued estimates for Abbott Laboratories’ Q2 2025 earnings at $1.26 EPS, Q3 2025 earnings at $1.30 EPS, Q4 2025 earnings at $1.48 EPS, Q1 […]
Abbott Laboratories (NYSE:ABT – Get Free Report) was upgraded by investment analysts at Leerink Partnrs to a “hold” rating in a note issued to investors on Monday,Zacks.com reports. Leerink Partnrs also issued estimates for Abbott Laboratories’ Q2 2025 earnings at $1.26 EPS, Q3 2025 earnings at $1.30 EPS, Q4 2025 earnings at $1.48 EPS, Q1 […]
